Target intelligence / Profile preview

Lin-9 DREAM MuvB core complex component (LIN9)

Target
LIN9
Molecular classification
Transcription factor, Cell cycle regulator, DREAM/MuvB complex component[1][2][3][4]
01

Overview

Lin-9 DREAM MuvB core complex component (LIN9) is a tumor suppressor protein and critical regulator of the cell cycle, acting as a core member of the MuvB multiprotein complex. In quiescent cells, LIN9 partners with p130, E2F4/DP1 to form the DREAM complex, which represses expression of E2F target genes and other cell cycle genes. When the cell re-enters the cycle, the MuvB core (including LIN9) dissociates from the repressive module and instead recruits transcription factors such as B-Myb and FoxM1, enabling activation of G2/M genes essential for mitosis. LIN9 thus serves as a molecular switch, coordinating repression of proliferation genes in non-dividing cells and their activation during proliferation. Dysfunction or altered regulation of LIN9/MuvB is implicated in tumorigenesis, as well as in HPV-mediated cell cycle dysregulation via viral oncoprotein interaction. LIN9 is a scaffold protein for other MuvB subunits, assembling with RBAP48, LIN52, LIN37, and LIN54 to mediate these critical transcriptional roles[1][2][3][4][6][8].

Other names
Protein lin-9 homologBARATGSHuLin-9hLin-9BARPsvTGS1TGS2Beta subunit-associated regulator of apoptosisTUDOR gene similar proteinType I interferon receptor beta chain-associated proteinpRB-associated proteinRb related pathway actorPRB-associated proteinLIN-9[1][3][5]
02

Mechanism of action

Experimental: Disruption of MuvB protein-protein interfaces to alter cell cycle gene expression, particularly in cancers with B-Myb overexpression (preclinical target concepts)[6]

03

Biological functions

Cell cycle regulationTranscriptional repression and activation (cell cycle-dependent genes)Tumor suppressionInhibition of DNA synthesisRegulation of G2/M gene expressionInteraction with pRB (retinoblastoma protein) family and E2F4/DP1 complexControl of cell proliferation and quiescence[1][2][3][8]
04

Disease associations

CancerRetinoblastomaProliferative disorders[1][3][6][8]
05

Safety considerations

Potential for broad cell cycle dysregulation if function impairedDepletion impairs cellular proliferation and can cause checkpoint defects[1][3]
06

Interacting drugs

None established or approved
07

Biomarkers

No validated clinical biomarkers specific for LIN9; expression/alteration may be studied in molecular oncology contexts as part of MuvB/DREAM complex status[3][6]

Beyond the preview

Go deeper on Lin-9 DREAM MuvB core complex component (LIN9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lin-9 DREAM MuvB core complex component (LIN9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call